Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$612K Sell
7,232
-21,475
-75% -$1.73M 0.15% 257
2026
Q1
$2.03M Buy
28,707
+22,992
+402% +$1.72M 0.49% 15
2025
Q4
$451K Buy
5,715
+2,478
+77% +$196K 0.13% 306
2025
Q3
$267K Sell
3,237
-8,263
-72% -$650K 0.06% 499
2025
Q2
$925K Buy
+11,500
New +$887K 0.21% 166
2024
Q2
Sell
-13,016
Closed -$965K 754
2024
Q1
$965K Buy
13,016
+1,087
+9% +$75.8K 0.25% 150
2023
Q4
$789K Buy
11,929
+5,330
+81% +$334K 0.56% 24
2023
Q3
$415K Buy
+6,599
New +$411K 0.24% 186
2023
Q2
Sell
-8,120
Closed -$470K 551
2023
Q1
$470K Sell
8,120
-5,511
-40% -$372K 0.15% 254
2022
Q4
$986K Buy
+13,631
New +$976K 0.52% 26

Other funds holding MET

InceptionR's MET Position: Q2 2026 in Review

InceptionR reduced its MetLife (MET) stake by 75% in Q2 2026, selling an estimated $1.73M and leaving 7,232 shares worth $612K. The position accounts for 0.15% of the portfolio, ranked #257.

InceptionR first reported a position in MET in Q4 2022 and has held it in 10 quarters since. The position peaked at $2.03M in Q1 2026. 1,445 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • InceptionR held 7,232 shares of MetLife worth $612K as of Q2 2026.
  • InceptionR sold 21,475 MetLife shares in Q2 2026, an estimated $1.73M.
  • MetLife made up 0.15% of InceptionR's portfolio in Q2 2026, its #257 holding.
  • InceptionR first reported a position in MetLife in Q4 2022 and has held it in 10 quarters since.
  • InceptionR's MetLife position peaked at $2.03M in Q1 2026.
  • 1,445 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on InceptionR's 13F filing for Q2 2026, filed 11 Aug 2026.